Schooler Nina R
Department of Psychiatry, Georgetown University School of Medicine, 3800 Reservoir Road NW, Washington, DC 20007, USA.
J Clin Psychiatry. 2006;67 Suppl 5:19-23.
Nonadherence to medication is a predictor of relapse in patients diagnosed with schizophrenia, and preventing relapse is crucial to achieving the goal of recovery. Long-term treatment with antipsychotics can be effective, although long-term patient response to medication may be difficult to predict from trials that measure response, remission, and relapse rates because they are often too short. Longer trials are needed to fully understand the implications of adherence and symptom remission in patient outcome. Recovery, however, is contingent on the stabilization of the symptoms of schizophrenia and the acquisition of the skills necessary to function in society. Psychosocial interventions, such as family psychoeducation, social skills training, and cognitive-behavioral therapy, used in conjunction with pharmacotherapy are effective in helping to prevent symptom relapse and promote functional recovery in patients with schizophrenia.
不坚持服药是精神分裂症患者复发的一个预测因素,而预防复发对于实现康复目标至关重要。抗精神病药物的长期治疗可能有效,尽管从衡量反应、缓解和复发率的试验中往往难以预测患者对药物的长期反应,因为这些试验通常时间过短。需要更长时间的试验来充分了解坚持服药和症状缓解对患者预后的影响。然而,康复取决于精神分裂症症状的稳定以及获得在社会中发挥作用所需的技能。心理社会干预,如家庭心理教育、社交技能训练和认知行为疗法,与药物治疗联合使用,在帮助预防精神分裂症患者症状复发和促进功能恢复方面是有效的。